TrialJournal of cancer research and clinical oncology2008

A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer.

Martina Baur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.